Synapse - Gary Schwartz

Results (385)

A phase 1 dose-escalation study of irinotecan in combination with 17-allylamino-17-demethoxygeldanamycin in patients with solid tumors

Journal Article

Tse, A. N.; Klimstra, D. S.; Gonen, M.; Shah, M.; Sheikh, T.; Sikorski, R.; Carvajal, R.; Mui, J.; Tipian, C.; O'reilly, E.; more...
Clinical Cancer Research (2008)

Fulltext@MSK | Save

A developmental model of sarcomagenesis defines a differentiation-based classification for liposarcomas

Journal Article

Matushansky, I.; Hernando, E.; Socci, N. D.; Matos, T.; Mills, J.; Edgar, M. A.; Schwartz, G. K.; Singer, S.; Cordon-Cardo, C.; Maki, R. G.
American Journal of Pathology (2008)

Fulltext@MSK | Save

Phase II trial of sequential paclitaxel and 1 h infusion of bryostatin-1 in patients with advanced esophageal cancer

Journal Article

Ku, G. Y.; Ilson, D. H.; Schwartz, L. H.; Capanu, M.; O'reilly, E.; Shah, M. A.; Kelsen, D. P.; Schwartz, G. K.
Cancer Chemotherapy and Pharmacology (2008)

Fulltext@MSK | Save

A phase I study of erlotinib in combination with gemcitabine and radiation in locally advanced, non-operable pancreatic adenocarcinoma

Journal Article

Duffy, A.; Kortmansky, J.; Schwartz, G. K.; Capanu, M.; Puleio, S.; Minsky, B.; Saltz, L.; Kelsen, D. P.; O'Reilly, E. M.
Annals of Oncology (2008)

Fulltext@MSK | Save

The cyclin-dependent kinase inhibitor flavopiridol potentiates the effects of topoisomerase I poisons by suppressing Rad51 expression in a p53-dependent manner

Journal Article

Ambrosini, G.; Seelman, S. L.; Qin, L. X.; Schwartz, G. K.
Cancer Research (2008)

Fulltext@MSK | Save

Sorafenib inhibits growth and mitogen-activated protein kinase signaling in malignant peripheral nerve sheath cells

Journal Article

Ambrosini, G.; Cheema, H. S.; Seelman, S.; Teed, A.; Sambol, E. B.; Singer, S.; Schwartz, G. K.
Molecular Cancer Therapeutics (2008)

Fulltext@MSK | Save

Phase 1 dose-escalation study of 17-allylamino-17-demethoxygeldanamycin (17AAG) in combination with irinotecan in patients with solid tumors

Meeting Abstract

Tse, A. N.; Carvajal, R.; Shah, M.; Dials, H.; Fogel, M.; O'Reilly, E.; Chung, K.; Maki, R.; Wu, N.; Egorin, M.; more...
Journal of Clinical Oncology (2007)

Fulltext@MSK | Save

A phase I dose escalation trial of a daily oral CDK 4/6 inhibitor PD-0332991

Meeting Abstract

O'Dwyer, P. J.; LoRusso, P.; DeMichele, A.; Gupta, V.; Barbi, A.; Dials, H.; Chen, I.; Courtney, R.; Wilner, K.; Schwartz, G. K.
Journal of Clinical Oncology (2007)

Fulltext@MSK | Save

Evaluation of the feasibility of expression microarray analysis in endoscopically obtained biopsies of gastric carcinoma and their clinical applicability

Meeting Abstract

Jhawer, M. P.; Qin, L.; Gerdes, H.; Klimstra, D.; Schattner, M.; Viale, A.; Gonen, M.; Schwartz, G.; Kelsen, D.; Shah, M.
Journal of Clinical Oncology (2007)

Fulltext@MSK | Save

Prognostic factors (PF) in advanced hepatocellular carcinoma (AHCC): Multivariate analysis and comparison between staging systems (SS) in patients (pts) treated at Memorial Sloan-Kettering Cancer Center (MSKCC)

Meeting Abstract

Huitzil, F. D.; Capanu, M.; Jacobs, G.; Smith, W.; O'Reilly, E.; Shah, M.; Schwartz, G. K.; Saltz, L. B.; Kelsen, D. P.; Abou-Alfa, G. K.
Journal of Clinical Oncology (2007)

Fulltext@MSK | Save